Monashee Investment Management LLC Viking Therapeutics, Inc. Transaction History

Monashee Investment Management LLC

  • $774 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 05, 2023
BUY
$8.08 - $17.33 $2.42 Million - $5.2 Million
300,000 New
300,000 $5 Million
Q4 2018

Feb 12, 2019
SELL
$7.16 - $16.21 $1.29 Million - $2.92 Million
-180,000 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$9.7 - $19.65 $291,000 - $589,500
30,000 Added 20.0%
180,000 $3.14 Million
Q2 2018

Aug 10, 2018
BUY
$3.88 - $12.74 $582,000 - $1.91 Million
150,000 New
150,000 $1.42 Million

Others Institutions Holding VKTX

# of Institutions
473
Shares Held
66.2M
Call Options Held
5.72M
Put Options Held
3.39M
View Full List

About Viking Therapeutics, Inc.

VKTX Quotes by TradingView
  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $4.03B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email